MENS Stock Analysis: Buy, Sell, or Hold?
MENS - Jyong Biotech Ltd. Ordinary Shares
$2.21
-0.09 (-3.91%)
▼
5d:
-0.45%
30d:
+22.1%
90d:
-17.54%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When MENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MENS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MENS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MENS is currently trading at $2.21, which is considered extended relative to its 30-day fair value range of $1.67 to $2.17.
Technical Outlook: Technically, MENS is in a downtrend. Immediate support is located at $1.82, while resistance sits at $2.40. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MENS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (77th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MENS is in a downtrend. Immediate support is located at $1.82, while resistance sits at $2.40. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MENS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (77th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.67 -
$2.17
Company Quality Score
58/100
(HOLD)
Options IV Signal
77th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
40.9%
All Signals
- BEARISH: Price extended above range
- BEARISH: Options expensive (IV 77th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
Trading Range Analysis
30-Day Trading Range
$1.67 -
$2.17
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.65
(29.2%)
Support & Resistance Levels
Support Level
$1.82
Resistance Level
$2.40
Current Trend
Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 11, 2026 3:16 AM ET
Data refreshes hourly during market hours. Next update: 4:16 AM
Data refreshes hourly during market hours. Next update: 4:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MENS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 55 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 45 HOLD |